Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Regulated cell death pathways in kidney disease
Disorders of cell number that result from an imbalance between the death of parenchymal
cells and the proliferation or recruitment of maladaptive cells contributes to the pathogenesis …
cells and the proliferation or recruitment of maladaptive cells contributes to the pathogenesis …
Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease
M Fontecha-Barriuso, AM Lopez-Diaz… - Antioxidants, 2022 - mdpi.com
Acute kidney injury (AKI) and chronic kidney disease (CKD) are interconnected conditions,
and CKD is projected to become the fifth leading global cause of death by 2040. New …
and CKD is projected to become the fifth leading global cause of death by 2040. New …
Prevention of cardiorenal damage: importance of albuminuria
LM Ruilope, A Ortiz, A Lucia, B Miranda… - European Heart …, 2023 - academic.oup.com
Chronic kidney disease (CKD) is projected to become a leading global cause of death by
2040, and its early detection is critical for effective and timely management. The current …
2040, and its early detection is critical for effective and timely management. The current …
Molecular mechanisms of kidney injury and repair
S Rayego-Mateos, L Marquez-Expósito… - International journal of …, 2022 - mdpi.com
Chronic kidney disease (CKD) will become the fifth global cause of death by 2040, thus
emphasizing the need to better understand the molecular mechanisms of damage and …
emphasizing the need to better understand the molecular mechanisms of damage and …
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
ABSTRACT In the EMPA-KIDNEY (The Study of Heart and Kidney Protection With
Empagliflozin) trial, empagliflozin reduced cardiorenal outcomes by 28%(hazard ratio 0.72; …
Empagliflozin) trial, empagliflozin reduced cardiorenal outcomes by 28%(hazard ratio 0.72; …
Oxidative stress and cellular senescence are involved in the aging kidney
L Marquez-Exposito, L Tejedor-Santamaria… - Antioxidants, 2022 - mdpi.com
Chronic kidney disease (CKD) can be considered as a clinical model for premature aging.
However, non-invasive biomarkers to detect early kidney damage and the onset of a …
However, non-invasive biomarkers to detect early kidney damage and the onset of a …
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) …
P Sarafidis, F Iatridi, C Ferro… - Clinical Kidney …, 2023 - academic.oup.com
Chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) represents a major
public health issue; it develops in about 30%–40% of patients with diabetes mellitus and is …
public health issue; it develops in about 30%–40% of patients with diabetes mellitus and is …
Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis
F Trionfetti, V Marchant, GT González-Mateo… - International Journal of …, 2023 - mdpi.com
Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …
Ageing meets kidney disease
Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function,
present for˃ 3 months, with implications for health. The most used diagnostic criteria are a …
present for˃ 3 months, with implications for health. The most used diagnostic criteria are a …
Vitamin D, cellular senescence and chronic kidney diseases: what is missing in the equation?
As life expectancy increases in many countries, the prevalence of age-related diseases also
rises. Among these conditions, chronic kidney disease is predicted to become the second …
rises. Among these conditions, chronic kidney disease is predicted to become the second …